IDACIO
Live / Registered — Registered (as of 26 Sept 2023)
What this means for you
Registered since 26 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97373891
- Registration number
- 7177855
- Mark type
- Stylized text
- Filed
- 21 Apr 2022
- Published for opposition
- 22 Nov 2022
- Registered
- 26 Sept 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis; Pharmaceutical preparations for treating a wide variety of autoimmune diseases, illnesses and conditions
Owner
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
Prosecution history
- 26 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2023 — USE AMENDMENT FILED
- 02 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 17 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Nov 2022 — PUBLISHED FOR OPPOSITION
- 02 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE